# Ivermectin Reproposing for Mild Stage COVID-19 Outpatients

> **NCT04784481** · PHASE1,PHASE2 · COMPLETED · sponsor: **Ministry of Public Health, Argentina** · enrollment: 254 (actual)

## Conditions studied

- Covid19
- SARS (Severe Acute Respiratory Syndrome)

## Interventions

- **DRUG:** Ivermectin

## Key facts

- **NCT ID:** NCT04784481
- **Lead sponsor:** Ministry of Public Health, Argentina
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-20
- **Primary completion:** 2020-12-20
- **Final completion:** 2021-01-18
- **Target enrollment:** 254 (ACTUAL)
- **Last updated:** 2021-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04784481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04784481, "Ivermectin Reproposing for Mild Stage COVID-19 Outpatients". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT04784481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*